These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8885906)

  • 1. Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group.
    Fantl JA; Bump RC; Robinson D; McClish DK; Wyman JF
    Obstet Gynecol; 1996 Nov; 88(5):745-9. PubMed ID: 8885906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study.
    Grady D; Brown JS; Vittinghoff E; Applegate W; Varner E; Snyder T;
    Obstet Gynecol; 2001 Jan; 97(1):116-20. PubMed ID: 11152919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens.
    Sartori MG; Baracat EC; Girão MJ; Gonçalves WJ; Sartori JP; de Lima GR
    Int J Gynaecol Obstet; 1995 May; 49(2):165-9. PubMed ID: 7649322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group.
    Wyman JF; Fantl JA; McClish DK; Bump RC
    Am J Obstet Gynecol; 1998 Oct; 179(4):999-1007. PubMed ID: 9790388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estrogen with and without progestin on urinary incontinence.
    Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
    JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
    Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
    Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urinary diary in evaluation of incontinent women: a test-retest analysis.
    Wyman JF; Choi SC; Harkins SW; Wilson MS; Fantl JA
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):812-7. PubMed ID: 3368165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina.
    Schulman SP; Thiemann DR; Ouyang P; Chandra NC; Schulman DS; Reis SE; Terrin M; Forman S; de Albuquerque CP; Bahr RD; Townsend SN; Cosgriff R; Gerstenblith G
    J Am Coll Cardiol; 2002 Jan; 39(2):231-7. PubMed ID: 11788212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.
    Greenspan SL; Resnick NM; Parker RA
    JAMA; 2003 May; 289(19):2525-33. PubMed ID: 12759324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed urinary incontinence.
    Nygaard IE; Kreder KJ; Lepic MM; Fountain KA; Rhomberg AT
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):120-5. PubMed ID: 8571994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone therapy: does it cause incontinence?
    Steinauer JE; Waetjen LE; Vittinghoff E; Subak LL; Hulley SB; Grady D; Lin F; Brown JS
    Obstet Gynecol; 2005 Nov; 106(5 Pt 1):940-5. PubMed ID: 16260510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
    JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and costs of incontinence pads in female study volunteers. Continence Program for Women Research Group.
    McClish DK; Wyman JF; Sale PG; Camp J; Earle B
    J Wound Ostomy Continence Nurs; 1999 Jul; 26(4):207-8, 210-3. PubMed ID: 10476176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharma-clinics. Drug of the month. Premelle (conjugated estrogens + medroxyprogesterone].
    Scheen AJ
    Rev Med Liege; 1998 Oct; 53(10):638-40. PubMed ID: 9857760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.